STRAZZABOSCO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 22.266
EU - Europa 8.540
AS - Asia 4.108
SA - Sud America 65
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 18
AF - Africa 16
Totale 35.045
Nazione #
US - Stati Uniti d'America 21.890
CN - Cina 1.562
SE - Svezia 1.467
IE - Irlanda 1.240
SG - Singapore 1.240
IT - Italia 1.227
DE - Germania 1.151
UA - Ucraina 1.100
RU - Federazione Russa 1.003
HK - Hong Kong 757
GB - Regno Unito 520
CA - Canada 370
FI - Finlandia 286
VN - Vietnam 139
FR - Francia 138
IN - India 128
DK - Danimarca 103
TR - Turchia 91
AT - Austria 83
NL - Olanda 74
BE - Belgio 45
BR - Brasile 44
ID - Indonesia 35
JP - Giappone 35
EU - Europa 27
KR - Corea 26
BG - Bulgaria 23
IR - Iran 22
TW - Taiwan 20
ES - Italia 16
CZ - Repubblica Ceca 14
PK - Pakistan 11
AU - Australia 10
RO - Romania 10
CH - Svizzera 9
NZ - Nuova Zelanda 8
PH - Filippine 8
MY - Malesia 7
NO - Norvegia 7
PL - Polonia 7
CL - Cile 6
AR - Argentina 5
CO - Colombia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BD - Bangladesh 4
MD - Moldavia 4
MM - Myanmar 4
MX - Messico 4
SC - Seychelles 4
EC - Ecuador 3
GR - Grecia 3
PT - Portogallo 3
TH - Thailandia 3
EG - Egitto 2
IQ - Iraq 2
LK - Sri Lanka 2
LT - Lituania 2
MA - Marocco 2
MU - Mauritius 2
OM - Oman 2
TN - Tunisia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
SA - Arabia Saudita 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 35.045
Città #
Ann Arbor 3.259
Woodbridge 2.788
Fairfield 2.114
Houston 1.895
Chandler 1.334
Jacksonville 1.212
Dublin 1.204
Ashburn 1.144
Singapore 1.024
Wilmington 992
Seattle 870
Frankfurt am Main 799
Cambridge 769
Hong Kong 739
Dearborn 556
New York 552
Princeton 534
Santa Clara 393
Milan 365
Nanjing 290
Lawrence 228
Altamura 204
Lachine 197
Shanghai 176
Beijing 164
San Diego 128
Boardman 108
Guangzhou 82
Shenyang 82
Andover 76
Vienna 75
Nanchang 72
Toronto 69
Helsinki 67
Hebei 63
Ottawa 62
Falls Church 57
Changsha 53
Hangzhou 52
Jiaxing 50
Tianjin 50
Norwalk 48
Dong Ket 47
Mountain View 45
Fremont 43
London 42
Philadelphia 41
Jinan 38
Brussels 36
Huizen 36
Jakarta 35
Kunming 34
Los Angeles 31
Rome 30
Lissone 29
Redmond 29
Zhengzhou 29
Chicago 27
Pune 26
San Mateo 26
Ningbo 22
Auburn Hills 21
Plovdiv 20
Leawood 19
Taizhou 18
Boston 16
Tappahannock 16
Washington 16
Edmonton 15
Hefei 15
Nürnberg 15
Munich 14
Padova 14
Bologna 13
Fuzhou 13
Montréal 13
Bonndorf 12
Detroit 12
Kilburn 12
Dallas 11
Kiev 11
University Park 11
Hounslow 10
New Haven 10
Nuremberg 9
Tokyo 9
Auckland 8
Brno 8
Lanzhou 8
Old Lyme 8
Wuhan 8
Kuala Lumpur 7
Mumbai 7
Pisa 7
Shenzhen 7
Yongsan-gu 7
Bari 6
Bergamo 6
Busto Arsizio 6
Casalserugo 6
Totale 26.086
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 477
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 376
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 345
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 296
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 250
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 237
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 224
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 220
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 212
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 210
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 203
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 201
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 198
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 196
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 194
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 193
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 193
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 192
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 190
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 189
Health Related Quality of Life in the Major Liver Conditions 188
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 188
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 184
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 184
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 182
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 181
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 179
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 179
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 178
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 178
The impact of liver disease on the health-related quality of life 178
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 177
Health related quality of life in chronic liver diseases 177
Cholangiocyte biology as relevant to cystic liver diseases 176
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 176
Foxa1 and Foxa2 regulate bile duct development in mice 175
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 175
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 174
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 174
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 173
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 171
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 171
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 171
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 170
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 170
The challenges of primary biliary cholangitis: What is new and what needs to be done 169
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 168
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 167
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 165
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 165
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 165
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 163
Vascular biology of the biliary epithelium 162
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 161
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice 161
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 161
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 160
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 160
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 160
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 159
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 158
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 158
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 157
The cholangiopathies: disorders of biliary epithelia 156
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 156
Notch signaling and new therapeutic options in liver disease 156
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 156
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 156
Liver-allocation policies for patients affected by HCC in Europe 156
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 155
Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. 155
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 155
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 155
Functional anatomy of normal bile ducts 154
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 154
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 153
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 153
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 153
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 152
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 152
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 152
Intracellular pH regulation in isolated rat bile duct epithelial cells 151
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 151
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 151
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 151
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 150
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 150
Emerging concepts in biliary repair and fibrosis 150
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 149
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 149
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 149
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 148
Proinflammatory cytokines inhibit secretion in rat bile duct epithelium 148
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 148
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 148
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery 147
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 147
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 147
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 146
Totale 17.788
Categoria #
all - tutte 125.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.685 0 0 0 0 0 0 814 435 627 288 400 121
2020/20214.303 369 357 442 453 331 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20253.689 551 1.073 423 324 775 275 268 0 0 0 0 0
Totale 36.047